Tesla is building mobile molecule printers to produce a potential COVID-19 vaccine being developed in Germany by CureVac, reports Reuters:
CureVac, an unlisted German company, has said it is developing portable, automated mRNA production units that it calls printers and which Musk described as “RNA microfactories”. They are being designed to be shipped to remote locations, where they can churn out its vaccine candidate and other mRNA-based therapies depending on the recipe fed into the machine. But for the immediate pandemic use — should its vaccine candidate win market approval — it has production sites with regulatory approval in Germany with a capacity to produce hundreds of millions of doses. The company, based in Tuebingen and backed by the Bill & Melinda Gates Foundation, is a pioneer of the so-called messenger RNA approach, which is also pursued by BioNTech and its partner Pfizer as well as Moderna….
The “microfactories” would be built at Tesla Grohmann Automation in Germany, Musk said in a Twitter thread late on Wednesday night.